Novus International and Chr. Hansen have signed an agreement last week at World Pork Expo. This agreement combines the strengths of the two organizations in sales and technical competencies to position BioPlus 2B to the swine industry in the United States.

BioPlus 2B, a direct fed microbial, contains two strains of Bacillus (Bacillus licheniformis and Bacillus subtilis). These Bacillus strains can improve the intestinal microbial balance of swine. Safety studies have proven that BioPlus 2B strains are totally safe to animals and humans. The data was compiled into more than 5,000 pages to get final approval in the European Union for all swine categories. It makes BioPlus 2B the most extensively documented microbial for swine.

“This partnership complements our GEMS nutrition program and gut health management portfolio,” said Dan Meagher, vice president, Americas. “Novus International is focused on providing producers, nutritionists and veterinarians with ways to optimize pig health and performance.”

BioPlus 2B is an effective means of helping balance bacterial populations in the intestinal tract to improve performance regardless of life stage. BioPlus 2B  increases live weight gain and improves feed conversion efficiency when used in nursery and grow-finish applications. The product also helps improve overall intestinal health.

“The cooperation with Novus International immediately broadens our access to the swine market in the United States,” said Bill Braman, Chr. Hansen NA vice president, marketing and sales. "We expect strong growth in sales with this cooperation."